Long Island City, NY, United States of America

Foster Casimir Gonsalves

This inventor holds 6 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: New York University, Inspirna, Inc., Rgenix, Inc.. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Foster Casimir Gonsalves. Retrieved from https://idiyas.com/inventor/foster-casimir-gonsalves

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 4)

% Patents Active = 33.3

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 9(Granted Patents)

Location History:

Brooklyn, NY (US) (2015 - 2018)
Long Island City, NY (US) (2012 - 2024)

Company Filing History:

Years Active: 2012-2024

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12011427 - Methods of treating cancer (2024-06-18),

2. 10669296 - LXR agonists and uses thereof (2020-06-02),

3. 9874553 - Targeted chemical high-throughput screening method (2018-01-23),

4. 9433611 - Oxazole and thiazole compounds as β-catenin modulators and uses thereof (2016-09-06),

5. 9173871 - Oxazole and thiazole compounds as beta-catenin modulators and uses thereof (2015-11-03),

6. 8252823 - Oxazole and thiazole compounds as beta-catenin modulators and uses thereof (2012-08-28),

Title: Innovator in Cancer Research: Foster Casimir Gonsalves

Introduction

Foster Casimir Gonsalves is a distinguished inventor based in Long Island City, NY, who has made significant contributions to the field of cancer treatment through his innovative patents. With six patents to his name, Gonsalves has focused on developing methods and compounds aimed at improving therapeutic strategies for cancer patients.

Latest Patents

Among his latest patents are groundbreaking inventions for treating cancer. One notable invention involves methods of treating cancer using β-GPA, which include combinations of β-GPA with other anti-cancer therapies. Another critical contribution is related to LXR agonists, featuring compounds that modulate liver X receptors. This invention encompasses pharmaceutical compositions and methods that leverage these compounds for effective cancer treatment.

Career Highlights

Throughout his career, Gonsalves has collaborated with reputable institutions like New York University and Rgenix, Inc. His work emphasizes not only his innovative spirit but also his commitment to advancing cancer therapy and research through practical applications of science.

Collaborations

Foster Casimir Gonsalves has worked alongside notable colleagues such as Ramanuj Dasgupta and Isabel Kurth, contributing to a collaborative environment that fosters innovation in cancer research. These partnerships have played a crucial role in refining and advancing his inventions.

Conclusion

Foster Casimir Gonsalves exemplifies the role of an inventor dedicated to addressing significant health challenges through innovation. His patents reflect a commitment to developing effective cancer treatments, which can potentially transform the landscape of therapeutic practices.

Profile summary based on public USPTO records.